Sign inJoin waitlistJoin the waitlist

GA

George Ansstas

Physician · Washington University School of Medicine

Credentials: · · · · ·

History

Washington University School of Medicine
Present

Hematology and Medical Oncology
Washington University/B-JH/SLCH Consortium
2004–2007
Internal Medicine
SSM Health/Saint Louis University School of Medicine
2001–2004
Tishreen University Faculty of Medicine
1997–2001

Research

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
The Lancet · 2024 · 686 citations
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Neuro-Oncology · 2022 · 470 citations
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3…
JAMA Oncology · 2023 · 399 citations

Karam Khaddour
18 papers · 18 as a resident
Omar Butt
16 papers · 9 as a fellow
Tanner Johanns
16 papers · 1 as a fellow
AZ
Alice Zhou
15 papers · 2 as a resident
Jiayi Huang
13 papers
Jian Campian
10 papers
Jordan Phillipps
9 papers · 7 as a resident
Sonika Dahiya
9 papers
Albert Kim
8 papers · 2 as a resident
Milan Chheda
7 papers · 6 as a resident
RM
Renee Morecroft-Phillipps
7 papers · 6 as a resident
Lynn Cornelius
6 papers

Clinical trials

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Principal investigator · Not yet recruiting · Phase 2
Washington University School of Medicine
2026–2031
Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2022–2023
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
Principal investigator · Recruiting · Phase 2
Washington University School of Medicine
2020–2032
Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2019–2021